$HUM

2027 MA Star Ratings Released: Why it Matters for Providers

CMS released 2027 Medicare Advantage (MA) Star Ratings, showing a decline in 5-star contracts (15 down from 22). Humana saw 93% of plans rated 4+ stars, potentially adding $3B+ in 2028 revenue. UnitedHealthcare, Aetna, and Alignment Healthcare had mixed results. Ratings impact revenue, enrollment, and provider negotiations. Nonprofit MA plans outperform for-profit ones. CMS added new measures, including medication safety and functional outcomes.

Original reporting
Published Oct 12, 2026, 6:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 3:15 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
2027 MA Star Ratings Released: Why it Matters for Providers — source image
Decision brief

The 30-second read

$HUMBullishMed
01

Why it matters

The new ratings directly affect quality‑bonus payments and rebate allocations, creating immediate revenue implications for Humana, UnitedHealth, and CVS Health.

02

Market read

First‑report star rating data creates actionable insight for insurers' stock valuations ahead of the Medicare Open Enrollment Period.

03

What to watch

Potential policy changes by CMS or state Medicaid adjustments could mitigate rating impacts.

Relevance 7/10Novelty 7/10Timing: immediate following the Oct 8, 2026 star‑rating release

Background

CMS released the 2027 Medicare Advantage Star Ratings, showing a sector‑wide decline in star levels and highlighting winners and losers among major insurers.

Company-level read

Ticker impact

$HUMBullishHigh confidence
Context

Humana saw 93% of its plans rated 4 stars or higher, up from 41% in 2026, potentially adding $3B+ revenue in 2028.

Expected impact

likely upside as investors price in higher quality bonus payments.

Evidence & confidence

Star rating boost directly translates to a 5% quality bonus and larger rebate share, a material revenue driver.

Market effects

Medicare Advantage star rating changes could reshape enrollment flows and revenue expectations across the health‑insurance sector.

U.S. Medicare market participants may see shifting enrollment patterns during the upcoming Open Enrollment Period.

Limited to U.S. health‑insurance firms; no direct global impact.

Counterpoint

Investors might view the rating declines as temporary and bet on a rebound in enrollment once plans adjust networks.

Key entities

  • Humana Inc.

    Health insurer benefiting from higher star ratings.

  • UnitedHealth Group Inc.

    Parent of UnitedHealthcare, facing rating decline.

  • CVS Health Corp.

    Owner of Aetna, experiencing rating downgrade.

Related articles

$HUMMed

Humana (HUM) Forms New Joint Venture To Fund CenterWell Clinic Growth

Humana (HUM) has formed a joint venture with BlackRock's HPS Investment Partners to expand its CenterWell Senior Primary Care clinics. HPS will become the majority owner, providing capital for growth and operations. The deal, valued at approximately $2.8 billion, is expected to close in Q4 2026 and may impact Humana's financials and strategic plans.

$HUMMedAI 8/10

Humana enters $2.8B primary care joint venture with BlackRock

Humana has formed a $2.8B joint venture with BlackRock to operate 150 senior primary care clinics, replacing a prior deal with Welsh, Carson, Anderson & Stowe. The transaction is expected to close by year-end, reducing Humana's liabilities and unlocking capital for CenterWell's growth. BlackRock will hold a majority stake, with CenterWell retaining management and minority ownership.

Med

Humana AB (HUM) To Be Delisted From Nasdaq Stockholm

Humana AB (HUM) will be delisted from Nasdaq Stockholm, with the last trading day set for 27 October 2026. The decision was made by Nasdaq Stockholm, according to the company. The impact on valuation will depend on further details, such as reasons for delisting and post-delist trading options.

$HUMMedAI 8/10

Humana Inc. Announces New Strategic Joint Venture With HPS Investment Partners, A Part Of BlackRock, To Manage CenterWell Senior Primary Care Clinics

Humana Inc. formed a joint venture with HPS Investment Partners, part of BlackRock, to manage 150 CenterWell clinics. BlackRock will acquire WCAS's stake for $2.8B, with plans to expand the network. The deal, closing in Q4 2026, reduces Humana's balance sheet liabilities and is not expected to impact 2026 earnings guidance.

$HUMMed

BlackRock Steps Into Humana’s $2.8 Billion Clinic Venture

BlackRock is joining Humana's $2.8 billion clinic venture, CenterWell. The partnership may reduce Humana's reported liabilities and improve its leverage metrics. Evercore ISI notes CenterWell gains time to improve clinic profitability before ownership decisions begin in 2028. Humana aims to lower liabilities without affecting 2026 earnings.